Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

First-in-human study reveals activity of RAF-265 in melanoma

June 28, 2011

First-in-human data disclosed on ONX-0912 in recurrent/refractory solid tumors

June 28, 2011

First-in-human trial assesses azurin-derived P28 peptide in metastatic solid cancers

June 28, 2011

Phase Ib/II data suggest PCI-32765 is safe in lymphocytic leukemia/small lymphocytic lymphoma

June 28, 2011

Clovis Oncology expands study to identify patient stratification parameters for CP-4126 trial LEAP

June 28, 2011

New insulin-like growth factor I receptor inhibitors synthesized

June 28, 2011

Novel dual specificity protein kinase TTK inhibitors patented

June 28, 2011

E.U. approval recommended for Votubia in TSC-associated subependymal giant cell astrocytoma

June 27, 2011

EMA accepts Adcetris MAA in Hodgkin's and systemic anaplastic large cell lymphoma

June 27, 2011

New dUPTase inhibitors for cancer prepared at Taiho

June 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...